Global Automated Molecular Assay Market Growth (Status and Outlook) 2023-2029

Global Automated Molecular Assay Market Growth (Status and Outlook) 2023-2029

The global Automated Molecular Assay market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Automated Molecular Assay is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Automated Molecular Assay is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Automated Molecular Assay is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Automated Molecular Assay players cover F. Hoffmann-La Roche Ltd, Luminex Corporation, Molecular Devices LLC, Becton, Dickinson and Company, Siemens Healthcare GmbH, Tecan Trading AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc. and Invivoscribe, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Automation in molecular assay techniques helps to complete the laboratories procedures by laboratory robotics aided by the use of magnetic capture.

LPI (LP Information)' newest research report, the “Automated Molecular Assay Industry Forecast” looks at past sales and reviews total world Automated Molecular Assay sales in 2022, providing a comprehensive analysis by region and market sector of projected Automated Molecular Assay sales for 2023 through 2029. With Automated Molecular Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automated Molecular Assay industry.

This Insight Report provides a comprehensive analysis of the global Automated Molecular Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Automated Molecular Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Automated Molecular Assay market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automated Molecular Assay and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automated Molecular Assay.

This report presents a comprehensive overview, market shares, and growth opportunities of Automated Molecular Assay market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Blood Screening
Virus Screening
Genetic Material Testing
Oncological Testing
STD Testing

Segmentation by application
Infection Detection
Blood Donor Screening
Genomic Profiling
Molecular Biomarker Analysis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche Ltd
Luminex Corporation
Molecular Devices LLC
Becton, Dickinson and Company
Siemens Healthcare GmbH
Tecan Trading AG
Agilent Technologies Inc.
Thermo Fisher Scientific Inc.
Invivoscribe
Myriad Genetics Inc.
Hologic Inc.
bioMérieux SA
Abbott Laboratories
QIAGEN
Danaher Corporation
Illumina Inc.
Roche Holding AG
Enigma Diagnostics Ltd.
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
PerkinElmer Inc.
AutoGenomics
ELITech Group.

Please note: The report will take approximately 2 business days to prepare and deliver.